Skip to main content
Top

2013 | OriginalPaper | Hoofdstuk

19. Oncologische aandoeningen

Auteurs : drs. D. Bokkel ten Huinink, dr. R. van der Griend, dr. H.A.A.M. Maas

Gepubliceerd in: Het geriatrie formularium

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Steeds vaker zullen artsen beslissingen moeten nemen over ingrijpende antikankerbehandelingen bij zeer oude mensen. Van de maligne tumoren wordt 60-70% vastgesteld bij mensen boven de 65 jaar en de levensverwachting in rijke landen neemt toe.
Literatuur
1.
go back to reference Fayers PM, Palumbo A, Hulin C, Fayers PM, Palumbo A, Hulin C, Waage A,Wijermans P, Beksac¸ M, et al. Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials. Blood 2011;118:1239–47. Fayers PM, Palumbo A, Hulin C, Fayers PM, Palumbo A, Hulin C, Waage A,Wijermans P, Beksac¸ M, et al. Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials. Blood 2011;118:1239–47.
2.
go back to reference Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade´ J, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412–20.PubMedCrossRef Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade´ J, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412–20.PubMedCrossRef
3.
go back to reference Lichtman SM, Balducci L, Aapro M. Geriatric oncology: a field coming of age. J Clin Oncol 2007;25:1821–3.PubMedCrossRef Lichtman SM, Balducci L, Aapro M. Geriatric oncology: a field coming of age. J Clin Oncol 2007;25:1821–3.PubMedCrossRef
4.
go back to reference Lichtman SM,Wildiers H, Chatelut E, Steer C, Budman D, Morrison VA, et al. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients - an analysis of the medical literature. J Clin Oncol 2007;25:1832–43.PubMedCrossRef Lichtman SM,Wildiers H, Chatelut E, Steer C, Budman D, Morrison VA, et al. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients - an analysis of the medical literature. J Clin Oncol 2007;25:1832–43.PubMedCrossRef
5.
go back to reference Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J, et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005;105:1417–23.PubMedCrossRef Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J, et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005;105:1417–23.PubMedCrossRef
6.
go back to reference Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol 2011;12:460–8.PubMedCrossRef Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol 2011;12:460–8.PubMedCrossRef
7.
go back to reference Rijswijk RE van, Vermorken JB. Drug therapy for gynaecological cancer in older women. Drugs Aging 2000;17:13–32.PubMedCrossRef Rijswijk RE van, Vermorken JB. Drug therapy for gynaecological cancer in older women. Drugs Aging 2000;17:13–32.PubMedCrossRef
8.
go back to reference Sanoff HK, Bleiberg H, Goldberg RM. Managing older patients with colorectal cancer. J Clin Oncol 2007;25:1891–7.PubMedCrossRef Sanoff HK, Bleiberg H, Goldberg RM. Managing older patients with colorectal cancer. J Clin Oncol 2007;25:1891–7.PubMedCrossRef
9.
go back to reference Sonneveld P, Zweegman S, Vellenga E,Wittebol S, Sinnige HAM, Meijer E, et al, namens de HOVON Myeloom Werkgroep. Richtlijn behandeling plasmacelaandoeningen anno 2010. Ned Tijdschr Hematol 2010;7:84–95. Sonneveld P, Zweegman S, Vellenga E,Wittebol S, Sinnige HAM, Meijer E, et al, namens de HOVON Myeloom Werkgroep. Richtlijn behandeling plasmacelaandoeningen anno 2010. Ned Tijdschr Hematol 2010;7:84–95.
10.
go back to reference Terret C, Zulian GB, Naem A, Albrand G. Multidisciplinary approach to the geriatric oncology patient. J Clin Oncol 2007;25:1876–81.PubMedCrossRef Terret C, Zulian GB, Naem A, Albrand G. Multidisciplinary approach to the geriatric oncology patient. J Clin Oncol 2007;25:1876–81.PubMedCrossRef
11.
go back to reference Ziepert M, Hasenclever D, Kuhnt E, Glass B, Schmitz N, Pfreundschuh M, et al. Standard International Prognostic Index Remains a Valid Predictor of Outcome in Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era. J Clin Oncol 2010;28:2373–80.PubMedCrossRef Ziepert M, Hasenclever D, Kuhnt E, Glass B, Schmitz N, Pfreundschuh M, et al. Standard International Prognostic Index Remains a Valid Predictor of Outcome in Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era. J Clin Oncol 2010;28:2373–80.PubMedCrossRef
Metagegevens
Titel
Oncologische aandoeningen
Auteurs
drs. D. Bokkel ten Huinink
dr. R. van der Griend
dr. H.A.A.M. Maas
Copyright
2013
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-9265-0_19